Advertisement

β2-Glycoprotein-I (Apolipoprotein H): Possible Role in Platelet Activation and Coagulation

  • J. Nimpf
  • G. M. Kostner

Abstract

In 1961 Schultze et al. [1] described a new constituent of human plasma which was called β 2 -mucoid. Three years later Heide et al. found a carbohydrate-rich glycoprotein in human plasma which was called β 2 -glycoprotein because of its electrophoretical mobility [2]. Later, this glycoprotein was found to be identical to the previously described β 2 -mucoid [3].

Keywords

Sialic Acid Platelet Activation Procoagulant Activity Complete Amino Acid Sequence Triglyceride Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schultze HE, Heide K, Haupt H (1961) Über ein bisher unbekanntes niedermolekulares ß-Globulin des Humanserums. Naturwissenschaften 23: 719CrossRefGoogle Scholar
  2. 2.
    Heide K, Haupt H (1964) Darstellung noch nicht therapeutisch angewandter Plasmaproteine. Behringwerke Mitt 43: 161–193Google Scholar
  3. 3.
    Schultze HE, Heremans JF (1966) Methods of plasma fractionation. Mol Biol Hum Proteins 1: 221Google Scholar
  4. 4.
    Heimburger N, Heide K, Haupt H (1964) Bausteinanalyse von Humanserumproteinen. Clin Chim Acta 10: 293–307PubMedCrossRefGoogle Scholar
  5. 5.
    Haupt H, Heide K (1965) Isolierung und Eigenschaften eines ß2-Glykoproteins aus Human-serum. Clin Chim Acta 12: 419–424PubMedCrossRefGoogle Scholar
  6. 6.
    Cleve H, Rittner C (1969) Further family studies on the genetic control of ß-glycoprotein–1 concentration in human serum. Humangenetik 7: 93–97PubMedCrossRefGoogle Scholar
  7. 7.
    Kosaka S, Tohoku J (1977) ß2-Glycoprotein-I in rheumatoid arthritis. J Exp Med 122: 223–228Google Scholar
  8. 8.
    Cohnen G (1970) Immunochemical quantitation of ß-glycoprotein–1 in various diseases. J Lab Clin Med 75: 212–216PubMedGoogle Scholar
  9. 9.
    Chio LF, Oon CJ (1979) Changes in serum α1 antitrypsin, α1 acid glycoprotein and ß-glycoprotein in patients with malignant hepatocellular carcinoma. Cancer 43: 596–604PubMedCrossRefGoogle Scholar
  10. 10.
    Cleve H (1968) Genetic studies on the deficiency of ß-glycoprotein–1 of human serum. Humangenetik 5: 294–304PubMedCrossRefGoogle Scholar
  11. 11.
    Polz E (1979) Isolation of a specific lipid binding protein from human serum by affinitychromatography using heparinsepharose. In: Peeters H (ed) Protides of biological fluids. Pergamon, Oxford, pp 817–820Google Scholar
  12. 12.
    Finlayson JS, Mushinski JF (1967) Separation of subfractions of human ß2-glycoprotein-I. Bio-chim Biophys Acta 147: 413–420Google Scholar
  13. 13.
    Polz E, Wurm H, Kostner GM (1981) Studies on the composition of the protein part of triglyceriderich lipoproteins of human serum: isolation of polymorphic forms of ß2-glycoprotein-I. Artery 9: 305–315PubMedGoogle Scholar
  14. 14.
    PolzE, Kostner GM, Holasek A (1979) Studies on the protein composition of human serum very low lipoproteins: demonstration of the ß2-glycoprotein-I. Hoppe Seylers Z Physiol Chem 360: 1061–1067CrossRefGoogle Scholar
  15. 15.
    Schousboel (1983) Characterization of subfractions of ß2-glycoprotein-I: evidence for sialic acid microheterogeneity. Int J Biochem 15: 35–44CrossRefGoogle Scholar
  16. 16.
    Nakaya Y, Schaefer EJ, Brewer HB (1980) Activation of human post heparin lipoprotein lipase by apolipoprotein H (ß2-glycoprotein-I). Biochem Biophys Res Commun 95: 1168–1172PubMedCrossRefGoogle Scholar
  17. 17.
    Lee NS, Brewer HB, Osborne JC (1983) ß2-glycoprotein-I: molecular properties of an unusual apoliprotein, apolipoprotein H. J Biol Chem 258: 4765–4770PubMedGoogle Scholar
  18. 18.
    LozierJ, Takahashi N, Putnam FW (1984) Complete amino acid sequence of human plasma ß2-glycoprotein-I. Proc Natl Acad Sei USA 81: 3640–3644CrossRefGoogle Scholar
  19. 19.
    Canfield WM, Kisiel W (1982) Evidence of normal function levels of activated protein C inhibition in combined factor V/VIII deficiency desease. J Clin Invest 70: 1260–1272PubMedCrossRefGoogle Scholar
  20. 20.
    Burstein M, Scholnick HR (1972) Precipitation of chylomicrons and very low density lipoproteins from human with sodium lauryl sulfate. Life Sei 11: 177–184CrossRefGoogle Scholar
  21. 21.
    Burstein M, Legmann P (1978) Precipitation of triglyceride-rich lipoproteins by synthetic anionic detergents. Role of ß2-glycoprotein-I. In: Peeters H (ed) Protides of biological fluids. Pergamon, Oxford, pp 407–410Google Scholar
  22. 22.
    Polz E, Kostner GM (1979) The binding of ß-glycoprotein–1 to human serum lipoproteins. FEBS Lett 102: 183–186PubMedCrossRefGoogle Scholar
  23. 23.
    Polz E, Kostner GM (1979) Binding of ß2-glycoprotein-I to Intralipid: determination of the dissociation constant. Biochem Biophys Res Commun 90: 1305–1312PubMedCrossRefGoogle Scholar
  24. 24.
    PolzE, Wurm H, Kostner GM (1980) Investigation on ß2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem 11: 265–270CrossRefGoogle Scholar
  25. 25.
    Wurm H, Beubler E, Polz E, Kostner GM (1983) ß-glycoprotein–I: in vitro and in vivo studies with triglyceride-rich lipoproteins. In: CrepaldiG (ed) Arteriosclerotic brain disease. Raven, New York, pp 153–158Google Scholar
  26. 26.
    Wurm H, Beubler E, Polz E, Holasek A, Kostner GM (1982) Studies on the possible function of ß2-glycoprotein-I: influence in the triglyceride metabolism in the rat. Metabolism 31: 484–486PubMedCrossRefGoogle Scholar
  27. 27.
    KrollJ, LarsenJK, LoftH, EzbanM, WallevikK, FaberM (1976) DNA-binding proteins in Yoshida ascites fluid. Biochim Biophys Acta 434: 490–496Google Scholar
  28. 28.
    Schousboe I (1978) Characterization of an agglutinin from human serum. Biochim Biophys Acta 543: 373–382PubMedGoogle Scholar
  29. 29.
    Schousboe I (1982) Addition of deoxycholate in electroimmunoassay and crossed immunofocusing for quantification of ß2-glycoprotein-I and its subfractions. J Biochem Biophys Methods 6: 105–114PubMedCrossRefGoogle Scholar
  30. 30.
    Schousboel (1980) Binding of ß2-glycoprotein-I to platelets: effect on adenylate cyclase activity. Thromb Res 19: 225–237CrossRefGoogle Scholar
  31. 31.
    Wurm H (1984) ß2-glycoprotein-I (apolipoprotein-H) interaction with phospholipid vesicles. Int J Biochem 16: 511–515PubMedCrossRefGoogle Scholar
  32. 32.
    Nimpf J, Wurm H, Kostner GM (1985) Interaction of ß-glycoprotein–1 with human blood platelets: influence upon the ADP-induced aggregation. Thromb Haemost 54: 397–401PubMedGoogle Scholar
  33. 33.
    Nimpf J, Wurm H, Kostner GM (1985) Wechselwirkung von ß2-glycoprotein-I (Apo-H) mit Blutplättchen. In: , pp 239–296Google Scholar
  34. 34.
    Nimpf J, Gries A, Wurm H, Kostner GM (1985) Influence of ß2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets. Thromb Haemost 54: 824–827PubMedGoogle Scholar
  35. 35.
    Nimpf J, Wurm H, Kostner GM (1986) ß2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis (in press)Google Scholar
  36. 36.
    Nimpf J, Nimpf M, Gries A, Pfeiffer KP, Wurm H, Kostner GM (1986) Plasma lipids, lipoproteins, and apoproteins in relation to platelet activation in normolipemic persons. Atheroma 1: 10–15Google Scholar
  37. 37.
    Rosing J, van Rijen JLML, Bevers EM, van Dieijen G, Comfurius P, Zwaal RFA (1985) The role of activated human platelets in prothrombin and factor X activation. Blood 65: 319–332PubMedGoogle Scholar
  38. 38.
    Chap HJ, Zwaal RFA, van Deenen LLM (1977) Action of highly purified phospolipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta 467: 146–164PubMedCrossRefGoogle Scholar
  39. 39.
    Bevers EM, Comfurius P, Zwaal RFA (1983) Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 736: 57–66PubMedCrossRefGoogle Scholar
  40. 40.
    Bevers EM, Comfurius P, van Rijn JLML, Hemker HC, Zwaal RFA (1982) Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122: 429–436PubMedCrossRefGoogle Scholar
  41. 41.
    Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC (1980) The role of phospholipids and factor Vm in the prothrombinase complex. J Biol Chem 255: 274–283PubMedGoogle Scholar
  42. 42.
    Van Dieijen G, Tans G, Rosing J, Hemker HC (1981) The role of phospholipid and factor VIIIm in the activation of bovine factor X. J Biol Chem 256: 3433–3442PubMedGoogle Scholar
  43. 43.
    Nimpf J, Bevers EM, Till U, Wurm H, Kostner GM, Zwaal RFA (1986) Prothrombinase activity of human platelets is inhibited by ß2-glycoprotein-I. Biochim Biophys Acta 884: 142–149PubMedGoogle Scholar
  44. 44.
    Schousboe I (1985) ß2-glycoprotein-I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66: 1086–1091PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • J. Nimpf
  • G. M. Kostner

There are no affiliations available

Personalised recommendations